0001104659-20-052226.txt : 20200428 0001104659-20-052226.hdr.sgml : 20200428 20200428123610 ACCESSION NUMBER: 0001104659-20-052226 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200428 DATE AS OF CHANGE: 20200428 EFFECTIVENESS DATE: 20200428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 20823571 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 03-31-2020 03-31-2020 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger (415) 801-8100 /s/ Robin L. Praeger San Francisco CA 04-27-2020 0 9 364636407 false INFORMATION TABLE 2 a20-17888_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 647798 101855 SH OTR 0 101855 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 804754 543753 SH OTR 0 543753 0 Gritstone Oncology, Inc. Common Stock 39868T105 18059047 3102929 SH OTR 0 3102929 0 Second Sight Medical Products, Inc. Common Stock 81362J100 558635 561612 SH OTR 0 4492975 0 Ocular Therapeutix, Inc. Common Stock 67576A100 10966151 2215384 SH OTR 0 2215384 0 CRISPR Therapeutics AG Common Stock H17182108 177224616 4205615 SH OTR 0 4205615 0 Veracyte, Inc. Common Stock 92337F107 29303444 1205407 SH OTR 0 1205407 0 Adverum Biotechnologies, Inc. Common Stock 00773U108 69056636 7068233 SH OTR 0 7068233 0 Akero Therapeutics, Inc. Common Stock 00973Y108 58015326 2736572 SH OTR 0 2736572 0